Ardana, the small-cap pharmaceutical company, yesterday put itself up for sale amid a potentially crippling cash crunch, marking what could be the second blow to the Scottish life science sector in less than a week.
Ardana, the small-cap pharmaceutical company, yesterday put itself up for sale amid a potentially crippling cash crunch, marking what could be the second blow to the Scottish life science sector in less than a week.
Ardana, the small-cap pharmaceutical company, yesterday put itself up for sale amid a potentially crippling cash crunch, marking what could be the second blow to the Scottish life science sector in less than a week.